共 50 条
- [31] Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+HER2-Early Breast CancerANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1258 - 1266Raheem, Farah论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USA Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USAOfori, Henry论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USA Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USASimpson, Lacey论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USA Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USAShah, Vishal论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USA Mayo Clin, 5881 E Mayo Blvd, Phoenix, AZ 85054 USA
- [32] Evaluation of CDK4/6 inhibitors in first-line in symptomatic and asymptomatic patients with metastatic breast cancerFUTURE ONCOLOGY, 2024, : 3443 - 3450Oner, Irem论文数: 0 引用数: 0 h-index: 0机构: Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, Turkiye Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, TurkiyeTurkel, Alper论文数: 0 引用数: 0 h-index: 0机构: Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, Turkiye Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, TurkiyeAnik, Hicran论文数: 0 引用数: 0 h-index: 0机构: Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, Turkiye Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, TurkiyeArslan, Ulku Yalcintas论文数: 0 引用数: 0 h-index: 0机构: Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, Turkiye Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, TurkiyeKaracin, Cengiz论文数: 0 引用数: 0 h-index: 0机构: Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, Turkiye Dr Abdurrahman Yurtaslan Ankara Oncol Res & Traini, Dept Med Oncol, Ankara, Turkiye
- [33] Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancerBREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : CP8 - 297Fang, Hehui论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R ChinaHuang, Doudou论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R ChinaYang, Fang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R ChinaGuan, Xiaoxiang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China
- [34] Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinomaCANCER SCIENCE, 2021, 112 (01) : 305 - 313Ye, Dingwei论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaLiu, Jiyan论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Med Oncol, Chengdu, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaZhou, Aiping论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Inst & Hosp, Dept Med Oncol, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaZou, Qing论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Canc Hosp, Dept Med Oncol, Nanjing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaLi, Hanzhong论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll Hosp, Dept Urol, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaFu, Cheng论文数: 0 引用数: 0 h-index: 0机构: Liaoning Canc Hosp & Inst, Dept Urol Surg Oncol, Shenyang, Liaoning, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaHu, Hailong论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ, Dept Urol, Hosp 2, Tianjin, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaHuang, Jian论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaZhu, Shaoxing论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaJin, Jie论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Dept Urol, Hosp 1, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaMa, Lulin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Hosp 3, Dept Urol, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaGuo, Jianming论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaXiao, Jun论文数: 0 引用数: 0 h-index: 0机构: Anhui Prov Hosp, Dept Urol, Hefei, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaPark, Se Hoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol, Seoul, South Korea Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaZhang, Dahong论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Prov Peoples Hosp, Dept Urol, Hangzhou, Zhejiang, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaQiu, Xiusong论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Dept Med Oncol, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaBao, Yuanyuan论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Dept Med Oncol, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaZhang, Lilin论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Dept Med Oncol, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaShen, Wei论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Dept Med Oncol, Beijing, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R ChinaBi, Feng论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Med Oncol, Chengdu, Peoples R China Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China
- [35] Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitorBREAST CANCER RESEARCH AND TREATMENT, 2025, 210 (02) : 405 - 416论文数: 引用数: h-index:机构:Molto, Consolacion论文数: 0 引用数: 0 h-index: 0机构: Queens Univ, Dept Oncol, Kingston, ON, Canada Queens Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON, Canada RS McLaughlin Durham Reg Canc Ctr, Oshawa, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaPrasla, Shopnil论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Joint Dept Med Imaging JDMI, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaCuthbert, Danielle论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada Univ Toronto, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaPathak, Neha论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada Univ Toronto, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaBerner-Wygoda, Yael论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada Univ Toronto, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaDi Lorio, Massimo论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada Univ Toronto, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaLi, Meredith论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada Univ Toronto, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaSavill, Jacqueline论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada Univ Toronto, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaMittal, Abhenil论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci North, Dept Oncol, Sudbury, ON, Canada Northern Ontario Sch Med NOSMU, Div Clin Sci, Sudbury, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada论文数: 引用数: h-index:机构:Jhaveri, Kartik论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Joint Dept Med Imaging JDMI, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, CanadaNadler, Michelle B.论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada Univ Toronto, Toronto, ON, Canada Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada
- [36] CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma CellsCANCERS, 2022, 14 (23)Terenziani, Rita论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, I-43126 Parma, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, ItalyGaletti, Maricla论文数: 0 引用数: 0 h-index: 0机构: INAIL Italian Workers Compensat Author, Dept Occupat & Environm Med Epidemiol & Hyg, I-00078 Rome, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, ItalyLa Monica, Silvia论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, I-43126 Parma, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, Italy论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Digiacomo, Graziana论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, I-43126 Parma, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, ItalyCavazzoni, Andrea论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, I-43126 Parma, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, ItalyCavallo, Delia论文数: 0 引用数: 0 h-index: 0机构: INAIL Italian Workers Compensat Author, Dept Occupat & Environm Med Epidemiol & Hyg, I-00078 Rome, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, Italy论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Petronini, Pier Giorgio论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, I-43126 Parma, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, ItalyBonelli, Mara论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, I-43126 Parma, Italy Univ Parma, Dept Med & Surg, I-43126 Parma, Italy
- [37] Comparison of healthcare resource utilization and costs of patients with HR+/HER2-advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitorsJOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 806 - 815Burne, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, Canada Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, CanadaBalu, Sanjeev论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Hlth Econ & Outcomes Res, E Hanover, NJ USA Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, CanadaGuerin, Annie论文数: 0 引用数: 0 h-index: 0机构: Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, Canada Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, CanadaBungay, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, Canada Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, CanadaSin, Roxana论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Hlth Econ & Outcomes Res, E Hanover, NJ USA Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, CanadaPaul, Mary Lisha论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Hlth Econ & Outcomes Res, E Hanover, NJ USA Anal Grp Inc, 1190 Ave Canadiens De Montreal,Tour Deloitte, Montreal, PQ H3B 0G7, Canada
- [38] Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinomaBIOORGANIC CHEMISTRY, 2025, 154Niu, Zizhou论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaShi, Zhichao论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaWu, Guoxiang论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaLiu, Yanping论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaXie, Weibin论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Univ, Med Sch, Sch Pharm, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaLiu, Fakai论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaFan, Tingting论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaShu, Kaifei论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaHuang, Qiuhua论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaDai, Mengmeng论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaZhi, Cailian论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaQiu, Cheng论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaLi, Yilin论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Univ, Med Sch, Sch Pharm, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaWu, Lihong论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaLiu, Funian论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaZhang, Yijie论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Univ, Med Sch, Sch Pharm, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaWu, Tingbiao论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaChen, Yan论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Univ, Med Sch, Sch Pharm, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaLiu, Zijian论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Kivita Innovat Drug Discovery Inst, Shenzhen 518057, Peoples R China Shenzhen Winkey Technol Co Ltd, Shenzhen 518000, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaHao, Yue论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Univ, Med Sch, Sch Pharm, Shenzhen 518055, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R ChinaJiang, Yuyang论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China
- [39] Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (02) : 207 - 217Kalu, Nene N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USAJohnson, Faye M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
- [40] CDK4/6 inhibitor plus endocrine therapy for advanced breast cancer: results from a web-based survey in JapanFUTURE ONCOLOGY, 2025, 21 (03) : 321 - 330Nakayama, Takahiro论文数: 0 引用数: 0 h-index: 0机构: Osaka Int Canc Inst, Dept Breast & Endocrine Surg, Osaka 5418567, Japan Osaka Int Canc Inst, Dept Breast & Endocrine Surg, Osaka 5418567, JapanXu, Linghua论文数: 0 引用数: 0 h-index: 0机构: Pfizer Japan Inc, Access & Value, Tokyo, Japan Osaka Int Canc Inst, Dept Breast & Endocrine Surg, Osaka 5418567, JapanMuramatsu, Yasuaki论文数: 0 引用数: 0 h-index: 0机构: Pfizer Japan Inc, Oncol Med Affairs, Tokyo, Japan Osaka Int Canc Inst, Dept Breast & Endocrine Surg, Osaka 5418567, Japan